Attached files
| file | filename |
|---|---|
| EX-99.3 - Q3 2018 NON-GAAP RECONCILIATIONS - Sabra Health Care REIT, Inc. | sbraex9932018q3.htm |
| EX-99.1 - Q3 2018 EARNINGS RELEASE - Sabra Health Care REIT, Inc. | sbraex9912018q3.htm |
| 8-K - 8-K - Sabra Health Care REIT, Inc. | sbra8-k2018q3.htm |
3Q 2018 SUPPLEMENTAL INFORMATION Dedicated to Value Creation. Committed to Our Operator Roots. Exhibit 99.2
CONTENT 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Summary - Triple-Net Summary - Senior Housing Managed Summary - Loans and Other Investments Development Pipeline NOI Concentrations Geographic Concentrations Lease Expirations 14 INVESTMENT ACTIVITY Year-to-Date Recent 16 CAPITALIZATION Overview Indebtedness Debt Maturity Credit Metrics and Ratings 20 FINANCIAL INFORMATION 2018 Outlook Update Condensed Consolidated Financial Statements - Statements of Income Condensed Consolidated Financial Statements - Balance Sheets Condensed Consolidated Financial Statements - Statements of Cash Flows FFO, Normalized FFO, AFFO and Normalized AFFO Components of Net Asset Value (NAV) 27 APPENDIX Disclaimer Reporting Definitions Discussion and Reconciliation of Certain Non-GAAP Financial Measures: http://www.sabrahealth.com/investors/financials/reports-presentations/non-gaap 2 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
COMPANY INFORMATION SENIOR MANAGEMENT Rick Matros Harold Andrews Jr. Talya Nevo-Hacohen Chairman of the Board, President Executive Vice President, Chief Executive Vice President, Chief and Chief Executive Officer Financial Officer and Secretary Investment Officer and Treasurer BOARD OF DIRECTORS Rick Matros Michael Foster Jeffrey Malehorn Chairman of the Board, President Lead Independent Director Director and Chief Executive Officer Craig Barbarosh Ronald Geary Milton Walters Director Director Director Robert Ettl Raymond Lewis Director Director CONTACT INFORMATION Sabra Health Care REIT, Inc. Transfer Agent 18500 Von Karman Avenue American Stock Transfer Suite 550 and Trust Company Irvine, CA 92612 6201 15th Avenue 888.393.8248 Brooklyn, NY 11219 sabrahealth.com 3 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
OVERVIEW Financial Metrics Dollars in thousands, except per share data Three Months Ended Nine Months Ended September 30, 2018 Revenues $ 151,802 $ 484,200 Net operating income 147,938 474,011 Cash net operating income 142,298 442,077 Diluted per share data attributable to common stockholders: EPS $ 0.20 $ 1.62 FFO 0.50 1.72 Normalized FFO 0.60 1.81 AFFO 0.54 1.68 Normalized AFFO 0.55 1.69 Dividends per common share 0.45 1.35 Capitalization and Market Facts Key Credit Metrics (2) Pro Forma September 30, 2018 September 30, 2018 Common shares outstanding 178.3 million Net Debt to Adjusted EBITDA 5.50x Common equity Market Capitalization $4.1 billion Including unconsolidated joint venture 5.94x Total Debt (1) $3.7 billion Interest Coverage 4.18x Total Enterprise Value (1) $7.8 billion Fixed Charge Coverage Ratio 3.88x Total Debt/Asset Value 50% Common stock closing price $23.12 Secured Debt/Asset Value 8% Common stock 52-week range $15.78 - $23.83 Unencumbered Assets/Unsecured Debt 214% Common stock ticker symbol SBRA Portfolio Dollars in thousands As of September 30, 2018 Property Count Investment Beds/Units Occupancy Percentage (3) Investment in Real Estate Properties, gross Triple-Net Portfolio: Skilled Nursing / Transitional Care 350 $ 4,236,602 39,848 82.6% Senior Housing - Leased 91 1,227,305 7,309 85.7 Specialty Hospitals and Other 22 618,493 1,085 88.9 Total Triple-Net Portfolio 463 6,082,400 48,242 Senior Housing - Managed 24 311,782 1,712 91.5 Consolidated Equity Investments 487 6,394,182 49,954 Unconsolidated Joint Venture Senior Housing - Managed 172 732,935 7,652 81.8 Total Equity Investments 659 7,127,117 57,606 Investment in Direct Financing Lease, net 1 23,313 Investments in Loans Receivable, gross (4) 22 62,424 Preferred Equity Investments, gross (5) 11 47,096 Includes 73 relationships in 44 U.S. states Total Investments 693 $ 7,259,950 and Canada (1) Includes Sabra’s 49% pro rata share of the debt of its unconsolidated joint venture. (2) Assumes that the remaining Care Capital Properties, Inc. (“CCP”) rent reductions and the full $19.0 million Genesis Healthcare, Inc. (“Genesis”) rent reduction were completed as of the beginning of the period presented. See page 19 of this supplement for important information about these credit metrics. (3) Occupancy Percentage is presented for the trailing twelve month period and one quarter in arrears, except for Senior Housing - Managed, which is presented for the trailing three month period. (4) Three of our investments in loans receivable contain purchase options on three Senior Housing developments with 126 beds/units. (5) Our preferred equity investments include investments in entities owning 10 Senior Housing developments with 1,090 beds/units and one Skilled Nursing/Transitional Care development with 120 beds/ units. 4 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
PORTFOLIO Summary - Triple-Net Portfolio Triple-Net Portfolio Dollars in thousands Cash NOI As of September 30, 2018 Three Months Ended Property Type Number of Properties Number of Beds/Units Investment September 30, 2018 June 30, 2018 Skilled Nursing/Transitional Care 350 39,848 $ 4,236,602 $ 91,533 $ 97,439 Senior Housing - Leased 91 7,309 1,227,305 21,741 21,918 Specialty Hospitals and Other 22 1,085 618,493 12,100 12,000 Total 463 48,242 $ 6,082,400 $ 125,374 $ 131,357 Same Store Triple-Net Portfolio (1) Dollars in thousands Cash NOI Three Months Ended Property Type Number of Properties September 30, 2018 June 30, 2018 Skilled Nursing/Transitional Care 350 $ 91,655 $ 92,313 Senior Housing - Leased 85 20,804 20,892 Specialty Hospitals and Other 22 12,100 12,000 Total 457 $ 124,559 $ 125,205 Operating Statistics Triple-Net Portfolio (2) Coverage EBITDAR EBITDARM Occupancy Percentage Skilled Mix Property Type 3Q 2018 2Q 2018 3Q 2018 2Q 2018 3Q 2018 2Q 2018 3Q 2018 2Q 2018 Skilled Nursing/Transitional Care 1.30x 1.32x 1.77x 1.79x 82.6% 82.3% 39.1% 38.5% Senior Housing - Leased 1.07x 1.06x 1.24x 1.24x 85.7% 86.0% NA NA Specialty Hospitals and Other 3.19x 3.27x 3.48x 3.55x 88.9% 86.3% NA NA Same Store Operating Statistics Triple-Net Portfolio (3) Coverage EBITDAR EBITDARM Occupancy Percentage Skilled Mix Property Type 3Q 2018 2Q 2018 3Q 2018 2Q 2018 3Q 2018 2Q 2018 3Q 2018 2Q 2018 Skilled Nursing/Transitional Care 1.32x 1.31x 1.83x 1.81x 82.2% 82.1% 37.0% 37.0% Senior Housing - Leased 1.06x 1.07x 1.24x 1.24x 85.6% 86.0% NA NA Specialty Hospitals and Other 5.93x 5.95x 6.42x 6.43x 70.9% 71.4% NA NA (1) Same store triple-net portfolio includes all facilities owned for the full period in both comparison periods. (2) EBITDAR Coverage, EBITDARM Coverage, Occupancy Percentage and Skilled Mix (collectively, “Operating Statistics”) for each period presented include only facilities owned by the Company as of the end of the current period for the duration that such facilities were classified as Stabilized Facilities. Operating Statistics are only included in periods subsequent to our acquisition except for (i) the legacy CCP tenants, which are presented as if these real estate investments were owned by Sabra during the entire period presented and reflect the previously announced rent repositioning program for certain of our tenants who were legacy tenants of CCP and (ii) EBITDAR Coverage and EBITDARM Coverage for the North American Healthcare portfolio is presented on a trailing twelve month basis and consists of the EBITDAR Coverage and EBITDARM Coverage, respectively, for facilities owned by Sabra in periods subsequent to our acquisition and underwritten stabilized EBTIDAR Coverage and EBITDARM Coverage, respectively, for periods preceding our acquisition. In addition, Operating Statistics are presented for the twelve months ended at the end of the respective period and one quarter in arrears. As such, Operating Statistics exclude assets acquired after June 30, 2018. (3) Same store Operating Statistics are presented for the twelve months ended at the end of the respective period and one quarter in arrears for Stabilized Facilities owned for the full period in both comparison periods except for the legacy CCP tenants, which are presented as if these real estate investments were owned by Sabra during the entire period presented and reflect the previously announced rent repositioning program for certain of our tenants who were legacy tenants of CCP. 5 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
PORTFOLIO Summary - Real Estate Continued Pro Forma Top 10 Relationships (1) Twelve Months Ended September 30, 2018 Number of Sabra % of Pro Forma Tenant Primary Facility Type Properties (2) Lease Coverage (3) Annualized Cash NOI (4) Senior Care Centers (5) Skilled Nursing 38 0.98x 10.2% Enlivant Assisted Living 183 NA 8.0% Avamere Family of Companies (5) Skilled Nursing 29 1.24x 7.2% Signature Healthcare Skilled Nursing 45 1.47x 6.2% Holiday AL Holdings LP (6) Independent Living 21 1.15x 5.9% North American Healthcare (7) Skilled Nursing 23 1.22x 5.9% Signature Behavioral Behavioral Hospitals 6 1.55x 5.5% Genesis Healthcare, Inc. (8) Skilled Nursing 26 1.20x 5.4% Cadia Healthcare Skilled Nursing 9 1.33x 5.1% Healthmark Group Skilled Nursing 18 1.23x 2.8% (1) Pro forma top 10 relationships assumes the previously announced rent repositioning program for certain of our tenants who were legacy tenants of CCP was completed at the beginning of the period presented. (2) Consists of properties directly owned by us and properties owned through our joint venture with Enlivant. (3) Lease Coverage for tenants is defined as the EBITDAR Coverage for Stabilized Facilities operated by the applicable tenant, unless there is a corporate guarantee and the guarantor level fixed charge coverage is a more meaningful indicator of the tenant’s ability to make rent payments. Lease Coverage is for the twelve months ended September 30, 2018 and is presented one quarter in arrears. Lease Coverage for legacy CCP tenants is presented as if these real estate investments were owned by Sabra during the entire period presented and reflects the previously announced rent repositioning program for certain of our tenants who were legacy tenants of CCP. (4) Pro Forma Annualized Cash NOI reflects the Senior Care Centers portfolio at the historical annual lease rate of $58.5 million as the leases for these assets were terminated during the three months ended September 30, 2018 due to non-payment of rent. Senior Care Centers is currently operating the facilities on a month-to-month basis. (5) Lease Coverage reflects guarantor level fixed charge coverage for these relationships. (6) Lease Coverage reflects guarantor level fixed charge coverage, pro forma for Holiday AL Holdings LP's recently announced termination agreement on facilities leased from New Senior Investment Group, Inc. The Holiday AL Holdings LP portfolio consists of 21 independent living communities that the Company underwrote at a 1.10x EBITDAR Coverage. (7) The North American Healthcare portfolio coverage is presented on a trailing twelve month basis and consists of the EBITDAR Coverage for facilities owned by Sabra in periods subsequent to our acquisition and underwritten stabilized EBITDAR Coverage for periods preceding our acquisition. (8) Lease Coverage reflects guarantor level fixed charge coverage, pro forma for rent reductions from Sabra and other Genesis landlords and the impact of recent refinancings. 6 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
PORTFOLIO Summary - Senior Housing Managed Senior Housing - Managed Portfolio Dollars in thousands Capital Expenditures Number of Number of Properties Units Investment Three Months Ended Nine Months Ended As of September 30, 2018 September 30, 2018 Wholly-Owned AL 16 956 $ 183,593 $ 283 $ 1,229 IL 8 756 128,189 508 716 24 1,712 311,782 791 1,945 Sabra’s Share of Unconsolidated JV (1) AL 172 7,652 732,935 1,330 3,717 Total 196 9,364 $ 1,044,717 $ 2,121 $ 5,662 Operator Enlivant 183 8,283 $ 859,150 $ 1,584 $ 4,898 Sienna 9 865 130,922 514 728 Other 4 216 54,645 23 36 Total 196 9,364 $ 1,044,717 $ 2,121 $ 5,662 Senior Housing - Managed Portfolio Operating Results (2) Dollars in thousands, except REVPOR Revenues Cash NOI Cash NOI Margin % REVPOR Occupancy Percentage 3Q 2018 2Q 2018 3Q 2018 2Q 2018 3Q 2018 2Q 2018 3Q 2018 2Q 2018 3Q 2018 2Q 2018 Wholly-Owned AL $ 12,441 $ 12,597 $ 3,019 $ 3,310 24.3% 26.3% $ 4,668 $ 4,737 92.5% 92.8% IL 4,962 4,848 1,773 1,891 35.7% 39.0% 2,195 2,174 90.3% 89.9% 17,403 17,445 4,792 5,201 27.5% 29.8% 3,478 3,514 91.5% 91.4% Sabra’s Share of Unconsolidated JV (1) AL 36,940 36,657 8,747 8,727 23.7% 23.8% 4,017 4,051 81.8% 80.5% Total $ 54,343 $ 54,102 $ 13,539 $ 13,928 24.9% 25.7% $ 3,835 $ 3,868 84.7% 83.8% Operator Enlivant $ 45,906 $ 45,728 $ 11,222 $ 11,355 24.4% 24.8% $ 4,172 $ 4,222 83.8% 82.4% Sienna 5,413 5,309 1,855 2,004 34.3% 37.7% 2,106 2,086 90.3% 90.3% Other 3,024 3,065 462 569 15.3% 18.6% 6,135 5,901 79.7% 86.3% Total $ 54,343 $ 54,102 $ 13,539 $ 13,928 24.9% 25.7% $ 3,835 $ 3,868 84.7% 83.8% (1) Reflects Sabra’s 49% pro rata share of applicable amounts related to its unconsolidated joint venture with Enlivant. (2) REVPOR and Occupancy Percentage include only facilities owned by the Company as of the end of the current period for the duration that such facilities were classified as Stabilized Facilities. In addition, revenues, Cash NOI and REVPOR have been adjusted for changes in the foreign currency exchange rate where applicable. 7 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
PORTFOLIO Summary - Loans and Other Investments Loans Receivable and Other Investments Dollars in thousands As of September 30, 2018 Weighted Weighted Average Average Interest Income Three Number of Contractual Annualized Effective Months Ended Loan Type Loans Property Type Principal Balance Book Value Interest Rate Interest Rate September 30, 2018 (1) Maturity Date Mortgage 1 Specialty Hospital $ 16,525 $ 16,525 10.0% 10.0% $ 410 01/31/27 04/30/21- Construction 2 Senior Housing 4,266 4,329 8.0% 7.7% 84 09/30/22 Mezzanine 1 Skilled Nursing 25,000 2,291 10.0% 41.9% 203 05/25/20 Pre-development 1 Senior Housing 2,357 2,357 9.0% 9.0% 54 04/01/20 01/31/18- Other 17 Multiple 41,619 39,002 7.7% 8.6% 611 08/31/28 22 89,767 64,504 8.8% 10.1% $ 1,362 Loan loss reserve — (1,249) $ 89,767 $ 63,255 Number of Other Income Investmen Total Funding Total Amount Three Months Ended Other Investment Type ts Property Type Commitments Funded Book Value Rate of Return September 30, 2018 (1) Skilled Nursing / Preferred Equity 11 Senior Housing $ 38,045 $ 38,045 $ 47,096 12.1% $ 1,289 (1) Includes income related to loans receivable and other investments held as of September 30, 2018. 8 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
PORTFOLIO Development Pipeline Proprietary Development Pipeline (1) Dollars in thousands As of September 30, 2018 Estimated Real Estate Value Investment Type Property Type Investment Amount (2) Upon Completion Skilled Skilled Skilled Weighted Nursing/ Nursing/ Nursing/ Average Certificate of Preferred Transitional Senior Transitional Senior Transitional Senior Initial Cash Occupancy State Loan Equity Care Housing Care Housing Care Housing Lease Yield Timing (3) Q1 2017- Indiana — 3 — 3 $ — $ 17,334 — $ 89,400 7.4% Q3 2017 Kentucky — 1 — 1 — 3,128 — 27,000 7.4% Q4 2015 Q4 2016- Ohio — 4 — 4 — 14,193 — 114,531 7.4% Q1 2019 Q3 2015- Texas 2 3 1 4 5,125 11,102 14,475 39,600 7.7% Q3 2018 2 11 1 12 $ 5,125 $ 45,757 $ 14,475 $ 270,531 7.4% Asset Transitioned to Real Estate Portfolio in 3Q 2018 Dollars in thousands Investment Type Property Type Investment Amount (2) Real Estate Value (4) Skilled Skilled Skilled Weighted Nursing/ Nursing/ Nursing/ Average Preferred Transitional Senior Transitional Senior Transitional Senior Initial Cash Loan Equity Care Housing Care Housing Care Housing Lease Yield — 2 — 2 $ — $ 8,660 $ — $ 24,966 7.0% New Assets in Real Estate Portfolio (5) Dollars in thousands As of September 30, 2018 Property Type Beds/Units Skilled Skilled Nursing/ Senior Senior Nursing/ Senior Senior % of Total Transitional Housing Housing Transitional Housing Housing Real Estate Real Estate State Care - Leased - Managed Care - Leased - Managed Value (4) Invested Arizona — 1 — — 48 — $ 10,348 0.2% California 1 — — 15 — — 7,372 0.1% Colorado — 2 — — 116 — 32,109 0.5% Florida — 1 — — 60 — 24,365 0.4% Illinois — 1 — — 46 — 5,622 0.1% Indiana — 1 — — 140 — 26,587 0.4% Louisiana 1 — — 144 — — 26,270 0.4% Minnesota — — 1 — — 72 15,450 0.2% Nevada — 1 — — 60 — 23,670 0.4% South Dakota — 1 — — 33 — 7,167 0.1% Tennessee — 1 — — 68 — 11,032 0.2% Texas 6 6 — 751 305 — 122,066 1.9% Virginia — 1 — — 60 — 23,000 0.3% Washington 1 — — 60 — — 13,641 0.2% Wisconsin — 2 2 — 55 74 26,634 0.4% Canada — — 1 — — 70 27,129 0.4% 9 18 4 970 991 216 $ 402,462 6.2% (1) Includes projects invested in or committed to as of September 30, 2018. (2) Investment amount excludes accrued and unpaid interest receivable. (3) Certificate of occupancy timing represents the period in which the certificate of occupancy has been received for a development project where construction has been completed or when the certificate of occupancy is expected to be received for a development project that is currently under construction. (4) Real estate value excludes capitalized acquisition costs. (5) Includes properties built since 2010 and included in real estate investments as of September 30, 2018. 9 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
PORTFOLIO NOI Concentrations (1) Pro Forma as of September 30, 2018 (2) RELATIONSHIP CONCENTRATION Senior Care Centers: 10.2% Enlivant: 8.0% Avamere Family of Companies: 7.2% Signature Healthcare: 6.2% Other: 62.5% Holiday AL Holdings LP: 5.9% ASSET CLASS CONCENTRATION Senior Housing - Leased: 15.4% Senior Housing - Managed: 9.6% Specialty Hospital Skilled Nursing/ and Other: 8.5% Transitional Care: 64.5% Interest and Other Income: 2.0% PAYOR SOURCE CONCENTRATION (3) Private Pay: 40.2% Non-Private: 59.8% (1) Concentrations are calculated using Annualized Cash NOI and reflect the Senior Care Centers portfolio at the historical annual lease rate of $58.5 million as the leases for these assets were terminated during the three months ended September 30, 2018 due to non-payment of rent. Senior Care Centers is currently operating the facilities on a month-to-month basis. Relationship and asset class concentrations use Annualized Cash NOI for real estate investments, investments in loans receivable and other investments, and investment in unconsolidated joint venture. Payor source concentration excludes Annualized Cash NOI from investments in loans receivable and other investments. We define Annualized Cash NOI as Annualized Revenues less operating expenses and non-cash revenues. (2) Assumes the previously announced rent repositioning program for certain of our tenants who were legacy tenants of CCP was completed at the beginning of the period presented. (3) Tenant and borrower revenue presented one quarter in arrears. 10 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
PORTFOLIO Geographic Concentrations Property Type As of September 30, 2018 Unconsolidated JV Skilled Nursing/ Senior Housing - Senior Housing - Specialty Hospitals % of Consolidated Senior Housing - Location Transitional Care Leased Managed and Other Consolidated Total Total Managed Total % of Total Texas 59 16 — 14 89 18.3% 31 120 18.2% Indiana 14 6 — — 20 4.1 21 41 6.2 Washington 15 2 — — 17 3.5 17 34 5.2 Oregon 16 4 — — 20 4.1 11 31 4.7 California 25 1 — 4 30 6.2 — 30 4.5 Kentucky 25 — — 1 26 5.3 1 27 4.1 Wisconsin 9 4 2 — 15 3.1 10 25 3.8 Ohio 6 — — — 6 1.2 15 21 3.2 Massachusetts 19 — — — 19 3.9 — 19 2.9 Pennsylvania 3 — 5 — 8 1.6 11 19 2.9 Other (34 states & Canada) 159 58 17 3 237 48.7 55 292 44.3 Total 350 91 24 22 487 100.0% 172 659 100.0% % of Consolidated Total 71.9% 18.7% 4.9% 4.5% 100.0% % of Total 53.1% 13.8% 3.7% 3.3% 73.9% 26.1% 100.0% Distribution of Beds/Units As of September 30, 2018 Property Type Unconsolidated JV Total Number Skilled Nursing/ Senior Housing - Senior Housing - Specialty Hospitals % of Consolidated Senior Housing - Location of Properties Transitional Care Leased Managed and Other Consolidated Total Total Managed Total % of Total Texas 120 7,271 1,447 — 366 9,084 18.2% 1,236 10,320 17.9% Indiana 41 1,547 409 — — 1,956 3.9 963 2,919 5.1 Kentucky 27 2,598 — — 40 2,638 5.3 55 2,693 4.7 California 30 2,156 102 — 340 2,598 5.2 — 2,598 4.5 Washington 34 1,699 165 — — 1,864 3.7 725 2,589 4.5 Oregon 31 1,561 377 — — 1,938 3.9 399 2,337 4.1 Massachusetts 19 2,320 — — — 2,320 4.6 — 2,320 4.0 Connecticut 16 1,824 140 — — 1,964 3.9 — 1,964 3.4 Wisconsin 25 788 258 74 — 1,120 2.3 665 1,785 3.1 North Carolina 15 1,454 237 — — 1,691 3.4 — 1,691 2.9 Other (34 states & Canada) 301 16,630 4,174 1,638 339 22,781 45.6 3,609 26,390 45.8 Total 659 39,848 7,309 1,712 1,085 49,954 100.0% 7,652 57,606 100.0% % of Consolidated Total 79.8% 14.6% 3.4% 2.2% 100.0% % of Total 69.1% 12.7% 3.0% 1.9% 86.7% 13.3% 100.0% 11 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
PORTFOLIO Geographic Concentrations Continued Investment (1) Dollars in thousands As of September 30, 2018 Property Type Total Number Skilled Nursing/ Senior Housing - Senior Housing - Specialty Hospitals Location of Properties Transitional Care Leased Managed and Other Total % of Total Texas 89 $ 586,916 $ 248,510 $ — $ 196,098 $ 1,031,524 16.1% California 30 436,727 35,901 — 222,018 694,646 10.9 Oregon 20 264,892 86,415 — — 351,307 5.5 Maryland 9 320,950 6,566 — — 327,516 5.1 New York 10 297,066 19,235 — — 316,301 5.0 Kentucky 26 231,573 — — 30,313 261,886 4.1 Indiana 20 174,427 59,888 — — 234,315 3.7 Washington 17 188,549 36,883 — — 225,432 3.5 Arizona 8 31,976 47,248 — 121,757 200,981 3.1 North Carolina 15 123,462 67,272 — — 190,734 3.0 Other (32 states & Canada) (2) 243 1,580,064 619,387 311,782 48,307 2,559,540 40.0 Total 487 $ 4,236,602 $ 1,227,305 $ 311,782 $ 618,493 $ 6,394,182 100.0% % of Total investment 66.2% 19.2% 4.9% 9.7% 100.0% (1) Excludes unconsolidated joint venture. (2) Investment balance in Canada is based on the exchange rate as of September 30, 2018 of $0.7751 per CAD $1.00. 12 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
PORTFOLIO Lease Expirations Lease Expirations (1) Dollars in thousands As of September 30, 2018 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 Thereafter Total Skilled Nursing/ Transitional Care Properties 3 — 35 9 2 14 17 14 21 56 140 311 Beds/Units 429 — 4,461 1,175 245 1,716 1,702 1,551 2,308 5,567 15,965 35,119 Annualized Revenues $3,713 $ — $34,738 $7,972 $ 5,069 $18,634 $17,801 $ 8,995 $23,307 $45,490 $190,641 $356,360 Senior Housing - Leased Properties — — — 2 10 1 6 12 1 10 47 89 Beds/Units — — — 143 569 49 403 633 52 472 4,803 7,124 Annualized Revenues $ — $ — $ — $1,070 $ 7,214 $ 539 $ 4,344 $10,386 $ 632 $ 6,821 $ 68,521 $ 99,527 Specialty Hospitals and Other Properties — — 8 — 4 — — — — 6 4 22 Beds/Units — — 106 — 152 — — — — 652 175 1,085 Annualized Revenues $ — $ — $ 1,210 $ — $ 4,088 $ — $ — $ — $ — $33,220 $ 12,973 $ 51,491 Total Properties 3 — 43 11 16 15 23 26 22 72 191 422 Total Beds/Units 429 — 4,567 1,318 966 1,765 2,105 2,184 2,360 6,691 20,943 43,328 Total Annualized Revenues $3,713 $ — $35,948 $9,042 $16,371 $19,173 $22,145 $19,381 $23,939 $85,531 $272,135 $507,378 % of Revenue 0.7% —% 7.1% 1.8% 3.2% 3.8% 4.4% 3.8% 4.7% 16.9% 53.6% 100.0% (1) Excludes (i) Senior Housing - Managed communities, (ii) 36 skilled nursing/transitional care facilities and two Senior Housing - Leased communities operated by Senior Care Centers as the leases for these assets were terminated during the three months ended September 30, 2018 and are month-to-month, (iii) two additional skilled nursing/transitional care facilities with month-to-month leases and (iv) one non-operational skilled nursing/transitional care facility. 13 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
INVESTMENT ACTIVITY Year-to-Date Investment Activity Dollars in thousands Initial Number of 2018 Amounts Rate of Return/Initial Location Investment Date Property Type Properties Beds/Units Invested (1) Cash Yield Real Estate Enlivant 01/02/18 Senior Housing - 11 631 $ 125,035 6.30% Managed North American Healthcare 01/10/18 & Skilled Nursing/ 2 263 42,917 8.00% Portfolio II 01/19/18 Transitional Care Parkside Prairie View 01/31/18 Senior Housing - 1 30 4,087 8.00% Leased Parkside Portfolio II 04/16/18 Senior Housing - 2 55 11,210 8.00% Leased Greenfield of Strasburg 04/30/18 Senior Housing - 1 36 6,340 7.75% Leased Poet's Walk of Sarasota 05/18/18 Senior Housing - 1 60 24,408 7.50% Leased Meridian Portfolio (2) 08/31/18 Senior Housing - 2 136 25,004 7.00% Leased Additions to Real Estate Various Multiple NA NA 20,897 6.47% Total Real Estate Investments 259,898 6.91% Preferred Equity Leo Brown Group - McCordsville (3) 09/15/15 Senior Housing 1 133 770 12.00% Leo Brown Group - North Willow (3) 10/23/15 Senior Housing 1 120 2,910 12.00% Leo Brown Group - Beavercreek II 03/21/18 Senior Housing 1 36 1,549 12.00% Total Preferred Equity Investments 5,229 12.00% Loans Receivable McKinney Construction Loan (3) 03/14/16 Senior Housing 1 27 811 8.00% Arlington Construction Loan (3) 06/01/17 Senior Housing 1 27 586 8.00% River Vista Mortgage Loan (3) 08/17/17 Specialty Hospital 1 NA 7,563 10.00% and Other Meridian Promissory Note 01/23/18 Skilled Nursing/ NA NA 700 10.00% Transitional Care Signature Working Capital Loan 05/07/18 Skilled Nursing/ NA NA 7,000 7.00% Transitional Care Total Loans Receivable 16,660 8.57% Unconsolidated Joint Venture Enlivant 01/02/18 Senior Housing - 172 7,652 352,749 6.30% Managed All Investments $ 634,536 6.66% (1) Real estate investments include capitalized acquisition costs. (2) Gross investment of $25.0 million; $8.6 million was used to repay our preferred equity investments in these properties, of which $3.9 million was converted into a promissory note held by Sabra, resulting in a net cash expenditure by Sabra of $20.2 million which was funded with proceeds held by exchange accommodation titleholders. (3) Initial investment occurred prior to 2018. Amounts invested in the current period reflect incremental fundings. 14 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
INVESTMENT ACTIVITY Recent MERIDIAN PORTFOLIO From Proprietary Development Pipeline Investment Date Beds/Units August 31, 2018 136 Investment Amount Property Type $25.0 million (1) Senior Housing - Leased Investment Type Annualized GAAP Income Real Estate $1.9 million Number of Properties Initial Cash Yield 2 7.00% Location Texas and Tennessee (1) Gross investment of $25.0 million; $8.6 million was used to repay our preferred equity investments in these properties, of which $3.9 million was converted into a promissory note held by Sabra, resulting in a net cash expenditure by Sabra of $20.2 million which was funded with proceeds held by exchange accommodation titleholders. 15 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
CAPITALIZATION Overview Debt Dollars in thousands Sabra's Share of As of September 30, 2018 Consolidated Debt Unconsolidated JV Debt Total Debt Secured debt $ 255,512 $ 377,185 $ 632,697 Revolving credit facility 619,000 — 619,000 Term loans 1,196,888 — 1,196,888 Senior unsecured notes 1,300,000 — 1,300,000 Total Debt 3,371,400 377,185 3,748,585 Deferred financing costs and premiums/discounts, net (2,806) (5,851) (8,657) Total Debt, Net $ 3,368,594 $ 371,334 $ 3,739,928 Revolving Credit Facility Dollars in thousands As of September 30, 2018 Credit facility availability $ 381,000 Credit facility capacity 1,000,000 Enterprise Value Dollars in thousands, except per share amounts As of September 30, 2018 Shares Outstanding Price Value Common stock 178,284,975 $ 23.12 $ 4,121,949 Consolidated Debt 3,371,400 Cash and cash equivalents (36,348) Consolidated Enterprise Value 7,457,001 Sabra’s share of unconsolidated joint venture debt 377,185 Sabra's share of unconsolidated joint venture cash and cash equivalents (6,945) Total Enterprise Value $ 7,827,241 Common Stock and Equivalents Weighted Average Common Shares Three Months Ended September 30, 2018 Nine Months Ended September 30, 2018 EPS, FFO and Normalized FFO AFFO and Normalized AFFO EPS, FFO and Normalized FFO AFFO and Normalized AFFO Common stock 178,283,635 178,283,635 178,276,895 178,276,895 Common equivalents 34,134 34,134 32,232 32,232 Basic common and common equivalents 178,317,769 178,317,769 178,309,127 178,309,127 Dilutive securities: Restricted stock and units 623,444 1,152,114 420,726 1,119,116 Diluted common and common equivalents 178,941,213 179,469,883 178,729,853 179,428,243 16 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
CAPITALIZATION Indebtedness Fixed | Variable Rate Debt Dollars in thousands Weighted Average As of September 30, 2018 Principal Effective Rate (1) % of Total Fixed Rate Debt Secured debt $ 157,012 3.87% 4.2% Unsecured senior notes 1,300,000 5.33% 34.7% Total fixed rate debt 1,457,012 5.17% 38.9% Variable Rate Debt (2) Secured debt 98,500 4.06% 2.6% Revolving credit facility 619,000 3.51% 16.5% Term loans 1,196,888 2.88% 31.9% Sabra’s share of unconsolidated joint venture variable rate debt 377,185 4.80% 10.1% Total variable rate debt 2,291,573 3.42% 61.1% Total Debt $ 3,748,585 4.10% 100.0% Secured | Unsecured Debt Dollars in thousands Weighted Average As of September 30, 2018 Principal Effective Rate (1) % of Total Secured Debt Secured debt $ 255,512 3.95% 6.8% Sabra’s share of unconsolidated joint venture secured debt 377,185 4.80% 10.1% Total secured debt 632,697 4.46% 16.9% Unsecured Debt Unsecured senior notes 1,300,000 5.33% 34.7% Revolving credit facility 619,000 3.51% 16.5% Term loans 1,196,888 2.88% 31.9% Total unsecured debt 3,115,888 4.03% 83.1% Total Debt $ 3,748,585 4.10% 100.0% (1) Weighted average effective interest rate includes private mortgage insurance and impact of interest rate swap and cap agreements. (2) Term loans include $845.0 million subject to swap agreements that fix LIBOR at a weighted average rate of 1.19%, and $69.8 million (CAD $90.0 million) and $27.1 million (CAD $35.0 million) subject to swap agreements that fix CDOR at 1.59% and 0.93%, respectively. Excluding these amounts, variable rate debt was 36.0% of Total Debt as of September 30, 2018. Additionally, unconsolidated joint venture debt includes $368.4 million subject to interest rate cap agreements that cap LIBOR at a weighted average rate of 2.89%. 17 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
CAPITALIZATION Debt Maturity Debt Maturity Schedule (1) Sabra's Share of Dollars in thousands Secured Debt Unsecured Senior Notes Term Loans Revolving Credit Facility Consolidated Debt Unconsolidated JV Debt Total Debt As of September 30, 2018 Principal Rate (2) Principal Rate (2) Principal Rate (2) Principal Rate (2) Principal Rate (2) Principal Rate (2) Principal Rate (2) 10/1/18 - 12/31/18 $ 1,085 3.72% $ — — $ — — $ — — $ 1,085 3.72% $ — —% $ 1,085 3.72% 2019 102,930 3.56% — — — — — — 102,930 3.56% — —% 102,930 3.56% 2020 4,578 3.46% — — 200,000 3.71% — — 204,578 3.70% 3,505 4.78% 208,083 3.72% 2021 20,039 3.46% 500,000 5.50% — — 619,000 3.51% 1,139,039 4.38% 13,381 4.78% 1,152,420 4.39% 2022 4,285 3.44% — — 996,888 3.65% — — 1,001,173 3.64% 6,230 4.77% 1,007,403 3.65% 2023 4,427 3.45% 200,000 5.38% — — — — 204,427 5.33% 6,609 4.77% 211,036 5.32% 2024 4,573 3.45% — — — — — — 4,573 3.45% 6,660 4.77% 11,233 4.24% 2025 4,725 3.46% — — — — — — 4,725 3.46% 188,866 4.77% 193,591 4.74% 2026 4,882 3.47% 500,000 5.13% — — — — 504,882 5.11% 81,497 4.97% 586,379 5.09% 2027 5,044 3.48% 100,000 5.38% — — — — 105,044 5.29% 70,437 4.69% 175,481 5.05% Thereafter 98,944 3.60% — — — — — — 98,944 3.60% — — 98,944 3.60% Total Debt 255,512 1,300,000 1,196,888 619,000 3,371,400 377,185 3,748,585 Premium, net — 14,860 — — 14,860 — 14,860 Deferred financing costs, net (2,685) (7,740) (7,241) — (17,666) (5,851) (23,517) Total Debt, Net $ 252,827 $ 1,307,120 $ 1,189,647 $ 619,000 $ 3,368,594 $ 371,334 $ 3,739,928 Wtd. avg. maturity/years 14.3 5.3 3.5 2.9 4.9 7.0 5.1 Wtd. avg. effective interest rate (3) 3.95% 5.33% 2.88% 3.51% 4.02% 4.80% 4.10% (1) Revolving Credit Facility is subject to two six-month extension options. (2) Represents actual contractual interest rates excluding private mortgage insurance and impact of interest rate derivative agreements. (3) Weighted average effective interest rate includes private mortgage insurance and impact of interest rate derivative agreements. 18 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
CAPITALIZATION Credit Metrics and Ratings Key Credit Metrics (1) Pro Forma December 31, 2017 (2) September 30, 2018 (3) Net Debt to Adjusted EBITDA (4)(5) 5.49x 5.50x Net Debt to Adjusted EBITDA - Including Unconsolidated Joint Venture (4)(5) 5.94x 5.94x Interest Coverage (4) 4.20x 4.18x Fixed Charge Coverage Ratio (4) 3.80x 3.88x Total Debt/Asset Value 50% 50% Secured Debt/Asset Value 8% 8% Unencumbered Assets/Unsecured Debt 220% 214% Cost of Permanent Debt (6) 4.04% 4.22% Unsecured Notes Ratings S&P (Stable outlook) BBB- Fitch (Negative outlook) BBB- Moody's (Stable outlook) Ba1 (1) Key credit statistics (except net debt to adjusted EBITDA) are calculated in accordance with the credit agreement relating to the revolving credit facility and the indentures relating to our unsecured senior notes. (2) Assumes that the Enlivant acquisition, the acquisition of the North American Healthcare Portfolio II, the remaining CCP and Genesis rent reductions and the transition of five skilled nursing/transitional care facilities to an existing Sabra operator were completed as of the beginning of the period presented. (3) Assumes that the remaining CCP rent reductions and the full $19.0 million Genesis rent reduction were completed as of the beginning of the period presented. (4) Based on the trailing twelve month period ended as of the date indicated. (5) Net Debt to Adjusted EBITDA is calculated based on Annualized Adjusted EBITDA, which is Adjusted EBITDA, as adjusted for annualizing adjustments that give effect to the acquisitions and dispositions completed during the respective period as though such acquisitions and dispositions were completed as of the beginning of the period presented. Net Debt to Adjusted EBITDA - Including Unconsolidated Joint Venture is calculated based on Annualized Adjusted EBITDA, as adjusted, which includes Annualized Adjusted EBITDA and is further adjusted to include the Company's share of the unconsolidated joint venture interest expense. See “Reconciliations of Non-GAAP Financial Measures” on our website at http://www.sabrahealth.com/investors/financials/reports-presentations/non-gaap for additional information. (6) Excludes revolving credit facility balance that had an interest rate of 3.51% and 2.81% as of September 30, 2018 and December 31, 2017, respectively. 19 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
FINANCIAL INFORMATION 2018 Outlook Update 2018 Full Year Guidance Low High Net income attributable to common stockholders $ 1.64 $ 1.67 Add: Depreciation and amortization of real estate assets 1.07 1.07 Depreciation and amortization of real estate assets related to unconsolidated joint venture 0.12 0.12 Net gain on sales of real estate (0.68) (0.68) Impairment of real estate 0.01 0.01 FFO attributable to common stockholders $ 2.16 $ 2.19 CCP merger and transition costs 0.01 0.01 Provision for doubtful accounts and loan losses, net 0.03 0.03 Other normalizing items (1) 0.07 0.07 Normalized FFO attributable to common stockholders $ 2.27 $ 2.30 FFO attributable to common stockholders 2.16 2.19 Stock-based compensation expense 0.04 0.04 Straight-line rental income adjustments (0.24) (0.24) Amortization of above and below market lease intangibles, net 0.03 0.03 Non-cash interest income adjustments (0.01) (0.01) Non-cash interest expense 0.06 0.06 Provision for doubtful straight-line rental income, loan losses and other reserves 0.06 0.06 Other non-cash adjustments related to unconsolidated joint venture 0.01 0.01 AFFO attributable to common stockholders $ 2.11 $ 2.14 CCP transition costs 0.01 0.01 Recovery of doubtful cash income (0.01) (0.01) Other normalizing items (1) 0.03 0.03 Normalized AFFO attributable to common stockholders $ 2.14 $ 2.17 The updated 2018 outlook reflects the following: • An assumption that no rental revenues are recognized from Senior Care Centers during the fourth quarter of 2018; • Updates to the Company’s Senior Housing - Managed portfolio based on actual performance through the third quarter and expected fourth quarter 2018 performance; and • Updates for the actual timing of the Company’s investments and dispositions and related impact to the balance of the Company's revolving credit facility. Except as otherwise noted above, the foregoing projections reflect management's view of current and future market conditions. There can be no assurance that the Company's actual results will not differ materially from the estimates set forth above. Except as otherwise required by law, the Company assumes no, and hereby disclaims any, obligation to update any of the foregoing projections as a result of new information or new or future developments. (1) Other normalizing items for FFO and AFFO include (i) $0.03 per diluted common share of capitalized issuance costs related to our preferred stock issuance that were written off as a result of the June 1, 2018 preferred stock redemption and (ii) $0.01 per diluted common share of legal fees related to the recovery of previously reserved cash rental income and non-Senior Housing - Managed operating expenses. These amounts are partially offset by $0.01 per diluted common share of other income related to legacy CCP investments. In addition, other normalizing items for FFO includes $0.04 per diluted common share of acceleration of above market lease intangible amortization related to the restructuring of an operator’s lease agreement. 20 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
FINANCIAL INFORMATION Condensed Consolidated Financial Statements Condensed Consolidated Statements of Income Dollars in thousands, except per share data Three Months Ended September 30, Nine Months Ended September 30, 2018 2017 2018 2017 Revenues: Rental income $ 130,467 $ 100,145 $ 418,951 $ 213,273 Interest and other income 3,932 4,090 12,823 8,062 Resident fees and services 17,403 7,554 52,426 17,840 Total revenues 151,802 111,789 484,200 239,175 Expenses: Depreciation and amortization 48,468 25,933 143,301 62,290 Interest 37,305 24,568 109,880 56,218 Operating expenses 12,611 5,102 37,034 11,929 General and administrative 8,022 12,944 25,160 24,159 Merger and acquisition costs 151 23,299 593 29,750 Provision for doubtful accounts and loan losses 8,910 5,149 9,449 7,454 Impairment of real estate — — 1,413 — Total expenses 115,467 96,995 326,830 191,800 Other income: Loss on extinguishment of debt — (553) — (553) Other income 1,336 51 4,156 3,121 Net gain on sales of real estate 14 582 142,445 4,614 Total other income 1,350 80 146,601 7,182 Income before loss from unconsolidated joint venture and income tax (expense) benefit 37,685 14,874 303,971 54,557 Loss from unconsolidated joint venture (1,725) — (3,626) — Income tax (expense) benefit (732) 195 (1,847) (161) Net income 35,228 15,069 298,498 54,396 Net (income) loss attributable to noncontrolling interests (10) 26 (22) 42 Net income attributable to Sabra Health Care REIT, Inc. 35,218 15,095 298,476 54,438 Preferred stock dividends — (2,561) (9,768) (7,682) Net income attributable to common stockholders $ 35,218 $ 12,534 $ 288,708 $ 46,756 Net income attributable to common stockholders, per: Basic common share $ 0.20 $ 0.11 $ 1.62 $ 0.58 Diluted common share $ 0.20 $ 0.11 $ 1.62 $ 0.57 Weighted-average number of common shares outstanding, basic 178,317,769 112,149,638 178,309,127 81,150,846 Weighted-average number of common shares outstanding, diluted 178,941,213 112,418,100 178,729,853 81,429,044 21 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
FINANCIAL INFORMATION Condensed Consolidated Financial Statements Condensed Consolidated Balance Sheets Dollars in thousands, except per share data September 30, 2018 December 31, 2017 (unaudited) Assets Real estate investments, net of accumulated depreciation of $419,225 and $340,423 as of September 30, 2018 and December 31, 2017, respectively $ 5,975,590 $ 5,994,432 Loans receivable and other investments, net 110,351 114,390 Investment in unconsolidated joint venture 344,341 — Cash and cash equivalents 36,348 518,632 Restricted cash 103,168 68,817 Lease intangible assets, net 142,919 167,119 Accounts receivable, prepaid expenses and other assets, net 197,622 168,887 Total assets $ 6,910,339 $ 7,032,277 Liabilities Secured debt, net $ 252,827 $ 256,430 Revolving credit facility 619,000 641,000 Term loans, net 1,189,647 1,190,774 Senior unsecured notes, net 1,307,120 1,306,286 Accounts payable and accrued liabilities 86,885 102,523 Lease intangible liabilities, net 87,602 98,015 Total liabilities 3,543,081 3,595,028 Equity Preferred stock, $.01 par value; 10,000,000 shares authorized, 5,750,000 shares issued and outstanding as of December 31, 2017 — 58 Common stock, $.01 par value; 250,000,000 shares authorized, 178,284,975 and 178,255,843 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively 1,783 1,783 Additional paid-in capital 3,505,877 3,636,913 Cumulative distributions in excess of net income (171,116) (217,236) Accumulated other comprehensive income 26,357 11,289 Total Sabra Health Care REIT, Inc. stockholders’ equity 3,362,901 3,432,807 Noncontrolling interests 4,357 4,442 Total equity 3,367,258 3,437,249 Total liabilities and equity $ 6,910,339 $ 7,032,277 22 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
FINANCIAL INFORMATION Condensed Consolidated Financial Statements Condensed Consolidated Statements of Cash Flows Dollars in thousands Nine Months Ended September 30, 2018 2017 Cash flows from operating activities: Net income $ 298,498 $ 54,396 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 143,301 62,290 Amortization of above and below market lease intangibles, net 4,193 637 Non-cash interest income adjustments (1,722) (137) Non-cash interest expense 7,548 5,288 Stock-based compensation expense 6,275 8,329 Loss on extinguishment of debt — 553 Straight-line rental income adjustments (34,404) (18,260) Provision for doubtful accounts and loan losses 9,449 7,454 Change in fair value of contingent consideration — (552) Net gain on sales of real estate (142,445) (4,614) Impairment of real estate 1,413 — Loss from unconsolidated joint venture 3,626 — Distributions of earnings from unconsolidated joint venture 6,494 — Changes in operating assets and liabilities: Accounts receivable, prepaid expenses and other assets, net (4,031) (5,565) Accounts payable and accrued liabilities (15,171) (56,561) Net cash provided by operating activities 283,024 53,258 Cash flows from investing activities: Acquisition of real estate (239,001) (393,064) Cash received in CCP merger — 77,858 Origination and fundings of loans receivable (41,448) (5,642) Origination and fundings of preferred equity investments (5,285) (2,713) Additions to real estate (21,695) (3,233) Repayments of loans receivable 48,282 8,710 Repayments of preferred equity investments 6,491 3,239 Investment in unconsolidated joint venture (354,461) — Net proceeds from the sales of real estate 290,864 11,723 Net cash used in investing activities (316,253) (303,122) Cash flows from financing activities: Net repayments of revolving credit facility (22,000) (137,000) Proceeds from term loans — 181,000 Principal payments on secured debt (3,202) (3,094) Payments of deferred financing costs (12) (15,316) Distributions to noncontrolling interests (107) — Preferred stock redemption (143,750) — Issuance of common stock, net (499) 319,026 Dividends paid on common and preferred stock (244,978) (86,813) Net cash (used in) provided by financing activities (414,548) 257,803 Net (decrease) increase in cash, cash equivalents and restricted cash (447,777) 7,939 Effect of foreign currency translation on cash, cash equivalents and restricted cash (156) 758 Cash, cash equivalents and restricted cash, beginning of period 587,449 34,665 Cash, cash equivalents and restricted cash, end of period $ 139,516 $ 43,362 23 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
FINANCIAL INFORMATION Condensed Consolidated Financial Statements Condensed Consolidated Statements of Cash Flows Continued Dollars in thousands Nine Months Ended September 30, 2018 2017 Supplemental disclosure of cash flow information: Interest paid $ 111,519 $ 48,836 Supplemental disclosure of non-cash investing and financing activities: Acquisition of business in CCP merger $ — $ 3,726,093 Assumption of indebtedness in CCP merger $ — $ (1,751,373) Stock exchanged in CCP merger $ — $ (2,052,578) 24 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
FINANCIAL INFORMATION FFO, Normalized FFO, AFFO and Normalized AFFO FFO, Normalized FFO, AFFO and Normalized AFFO Three Months Ended September 30, Nine Months Ended September 30, 2018 2017 2018 2017 Net income attributable to common stockholders $ 35,218 $ 12,534 $ 288,708 $ 46,756 Add: Depreciation and amortization of real estate assets 48,468 25,933 143,301 62,290 Depreciation and amortization of real estate assets related to noncontrolling interests (39) — (119) — Depreciation and amortization of real estate assets related to unconsolidated joint venture 5,214 — 15,929 — Net gain on sales of real estate (14) (582) (142,445) (4,614) Impairment of real estate — — 1,413 — FFO attributable to common stockholders $ 88,847 $ 37,885 $ 306,787 $ 104,432 Lease termination fee — (351) — (2,634) CCP merger and transition costs 380 27,576 1,720 33,983 Loss on extinguishment of debt — 553 — 553 Provision for doubtful accounts and loan losses, net 10,860 4,583 5,568 6,365 Other normalizing items (1) 6,430 51 9,402 163 Normalized FFO attributable to common stockholders $ 106,517 $ 70,297 $ 323,477 $ 142,862 FFO attributable to common stockholders $ 88,847 $ 37,885 $ 306,787 $ 104,432 Merger and acquisition costs (2) 151 23,299 593 29,750 Stock-based compensation expense 2,436 2,669 6,275 6,988 Straight-line rental income adjustments (10,652) (8,682) (34,404) (18,260) Amortization of above and below market lease intangibles, net 5,561 637 4,193 637 Non-cash interest income adjustments (548) (188) (1,722) (137) Non-cash interest expense 2,551 2,044 7,548 5,288 Non-cash portion of loss on extinguishment of debt — 553 — 553 Change in fair value of contingent consideration — 270 — (552) Provision for doubtful straight-line rental income, loan losses and other reserves 8,801 4,886 11,293 6,810 Other non-cash adjustments related to unconsolidated joint venture 118 — 1,132 — Other non-cash adjustments 25 30 55 215 AFFO attributable to common stockholders $ 97,290 $ 63,403 $ 301,750 $ 135,724 CCP transition costs 286 4,297 1,220 4,297 Lease termination fee — (351) — (2,634) Provision for (recovery of) doubtful cash income 108 263 (2,160) 443 Other normalizing items (1) 180 21 3,152 59 Normalized AFFO attributable to common stockholders $ 97,864 $ 67,633 $ 303,962 $ 137,889 Amounts per diluted common share attributable to common stockholders: Net income $ 0.20 $ 0.11 $ 1.62 $ 0.57 FFO $ 0.50 $ 0.34 $ 1.72 $ 1.28 Normalized FFO $ 0.60 $ 0.63 $ 1.81 $ 1.75 AFFO $ 0.54 $ 0.56 $ 1.68 $ 1.66 Normalized AFFO $ 0.55 $ 0.60 $ 1.69 $ 1.69 Weighted average number of common shares outstanding, diluted: Net income, FFO and Normalized FFO 178,941,213 112,418,100 178,729,853 81,429,044 AFFO and Normalized AFFO 179,469,883 112,693,779 179,428,243 81,741,288 (1) Other normalizing items for FFO and AFFO for the three and nine months ended September 30, 2018 include $6.3 million of acceleration of above market lease intangible amortization. In addition, the nine months ended September 30, 2018 includes $5.5 million of capitalized issuance costs related to our preferred stock issuance that were written off as a result of the June 1, 2018 preferred stock redemption and $0.6 million of expenses related to the previously anticipated refinancing of our senior notes, as well as legal fees related to the recovery of previously reserved cash rental income and non-Senior Housing - Managed operating expenses, partially offset by a contingency fee of $2.0 million earned during the period related to a legacy CCP investment and $0.9 million of interest income from a legacy CCP loan receivable that was fully repaid in June 2018, which represents the difference between the outstanding principal balance repaid and its discounted book value. (2) Merger and acquisition costs primarily relate to the CCP merger. 25 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
FINANCIAL INFORMATION Components of Net Asset Value (NAV) We disclose components of our business relevant to calculate NAV. We consider NAV to be a useful supplemental measure that assists both management and investors to estimate the fair value of our Company. The calculation of NAV involves significant estimates and can be calculated using various methods. Each individual investor must determine the specific methodology, assumptions and estimates to use to arrive at an estimated NAV of the Company. The components of NAV do not consider potential changes in our investment portfolio. The components include non-GAAP financial measures, such as Cash NOI. Although these measures are not presented in accordance with GAAP, investors can use these non-GAAP financial measures as supplemental information to evaluate our business. Pro Forma Annualized Cash NOI (1) Dollars in thousands Skilled Nursing/Transitional Care $ 368,431 Senior Housing - Leased 87,958 Senior Housing - Managed 54,966 Specialty Hospitals and Other 48,378 Pro forma Annualized Cash NOI (Excluding Loans Receivable and Other Investments) $ 559,733 Obligations Dollars in thousands Secured debt (2) $ 255,512 Unsecured senior notes (2) 1,300,000 Revolving credit facility 619,000 Term loans (2) 1,196,888 Sabra’s share of unconsolidated JV debt (3) 377,185 Total Debt 3,748,585 Add (less): Cash and cash equivalents and restricted cash (139,516) Sabra’s share of unconsolidated JV cash and cash equivalents and restricted cash (4) (12,304) Accounts payable and accrued liabilities 86,885 Net obligations $ 3,683,650 Other Assets Dollars in thousands Loans receivable and other investments, net $ 110,351 Accounts receivable, prepaid expenses and other assets, net (5) 46,764 Total other assets $ 157,115 Common Shares Outstanding Total shares 178,284,975 (1) Pro Forma Annualized Cash NOI reflects the Senior Care Centers portfolio at the historical annual lease rate of $58.5 million as the leases for these assets were terminated during the three months ended September 30, 2018 due to non-payment of rent. Senior Care Centers is currently operating the facilities on a month-to-month basis. Pro Forma Annualized Cash NOI also assumes the previously announced rent repositioning program for certain of our tenants who were legacy tenants of CCP was completed at the beginning of the period presented. (2) Amounts represent principal amounts due and exclude deferred financing costs, net and premiums/discounts, net. (3) Represents Sabra’s 49% share of unconsolidated Enlivant joint venture’s debt. (4) Represents Sabra’s 49% share of unconsolidated Enlivant joint venture’s cash and cash equivalents and restricted cash. (5) Includes assets that impact cash or NOI and excludes non-cash items. 26 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
APPENDIX Disclaimer Disclaimer This supplement contains “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. These statements may be identified, without limitation, by the use of “expects,” “believes,” “intends,” “should” or comparable terms or the negative thereof. Examples of forward- looking statements include all statements regarding our expected future financial position, results of operations, cash flows, liquidity, business strategy, growth opportunities, potential investments, and plans and objectives for future operations. Our actual results may differ materially from those projected or contemplated by our forward-looking statements as a result of various factors, including among others, the following: our dependence on the operating success of our tenants; operational risks with respect to our Senior Housing - Managed communities; the effect of our tenants declaring bankruptcy or becoming insolvent; our ability to find replacement tenants and the impact of unforeseen costs in acquiring new properties; the impact of litigation and rising insurance costs on the business of our tenants; our ability to implement the previously announced rent repositioning program for certain of our tenants who were legacy tenants of Care Capital Properties, Inc. on the timing or terms we have previously disclosed; our ability to dispose of facilities currently leased to Genesis Healthcare, Inc. and Senior Care Centers on the timing or terms we have disclosed; the possibility that Sabra may not acquire the remaining majority interest in the Enlivant joint venture; risks associated with our investments in joint ventures; changes in healthcare regulation and political or economic conditions; the impact of required regulatory approvals of transfers of healthcare properties; competitive conditions in our industry; our concentration in the healthcare property sector, particularly in skilled nursing/transitional care facilities and senior housing communities, which makes our profitability more vulnerable to a downturn in a specific sector than if we were investing in multiple industries; the significant amount of and our ability to service our indebtedness; covenants in our debt agreements that may restrict our ability to pay dividends, make investments, incur additional indebtedness and refinance indebtedness on favorable terms; increases in market interest rates; our ability to raise capital through equity and debt financings; changes in foreign currency exchange rates; the relatively illiquid nature of real estate investments; the loss of key management personnel or other employees; uninsured or underinsured losses affecting our properties and the possibility of environmental compliance costs and liabilities; the impact of a failure or security breach of information technology in our operations; our ability to maintain our status as a real estate investment trust (“REIT”); changes in tax laws and regulations affecting REITs (including the potential effects of the Tax Cuts and Jobs Act); compliance with REIT requirements and certain tax and tax regulatory matters related to our status as a REIT; and the ownership limits and anti-takeover defenses in our governing documents and under Maryland law, which may restrict change of control or business combination opportunities. Additional information concerning risks and uncertainties that could affect our business can be found in our filings with the Securities and Exchange Commission (the “SEC”), including Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2017. We do not intend, and we undertake no obligation, to update any forward-looking information to reflect events or circumstances after the date of this supplement or to reflect the occurrence of unanticipated events, unless required by law to do so. Note Regarding Non-GAAP Financial Measures This supplement includes the following financial measures defined as non-GAAP financial measures by the SEC: net operating income (“NOI”), Cash NOI, funds from operations attributable to common stockholders (“FFO”), Normalized FFO, Adjusted FFO (“AFFO”), Normalized AFFO, FFO per diluted common share, Normalized FFO per diluted common share, AFFO per diluted common share, Normalized AFFO per diluted common share and Adjusted EBITDA (defined below). These measures may be different than non-GAAP financial measures used by other companies, and the presentation of these measures is not intended to be considered in isolation or as a substitute for financial information prepared and presented in accordance with U.S. generally accepted accounting principles. An explanation of these non-GAAP financial measures is included under “Reporting Definitions” in this supplement and reconciliations of these non-GAAP financial measures to the GAAP financial measures we consider most comparable are included on the Investors section of our website at http://www.sabrahealth.com/investors/financials/reports-presentations/non-gaap. Tenant and Borrower Information This supplement includes information regarding certain of our tenants that lease properties from us and our borrowers, most of which are not subject to SEC reporting requirements. The information related to our tenants and borrowers that is provided in this supplement has been provided by, or derived from information provided by, such tenants and borrowers. We have not independently verified this information. We have no reason to believe that such information is inaccurate in any material respect. We are providing this data for informational purposes only. Sabra Information The information in this supplemental information package should be read in conjunction with the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other information filed with the SEC. The Reporting Definitions and Reconciliations of Non-GAAP Measures are an integral part of the information presented herein. On Sabra’s website, www.sabrahealth.com, you can access, free of charge, Sabra's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports file or furnished pursuant to Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, as soon as reasonably practicable after such material is filed with, or furnished to, the SEC. The information contained on Sabra’s website is not incorporated by reference into, and should not be considered a part of, this supplemental information package. All material filed with the SEC can also be accessed through its website, www.sec.gov. For more information, contact Investor Relations at (888) 393-8248 or investorrelations@sabrahealth.com. 27 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
APPENDIX Reporting Definitions Adjusted EBITDA* Adjusted EBITDA is calculated as earnings before interest, taxes, depreciation and amortization (“EBITDA”) excluding the impact of merger-related costs, stock-based compensation expense under the Company's long-term equity award program, and loan loss reserves. Adjusted EBITDA is an important non- GAAP supplemental measure of operating performance. Ancillary Supported Tenant A tenant, or one of its affiliates, that owns an ancillary business that depends on providing services to the residents of the properties leased by the affiliated operating company (Sabra’s tenant) for a meaningful part of the ancillary business's profitability and has below market EBITDAR coverage. Annualized Revenues The annual straight-line rental revenues under leases and interest and other income generated by the Company’s loans receivable and other investments based on amounts invested and applicable terms as of the end of the period presented. Annualized Revenues do not include tenant recoveries or additional rents. Cash Net Operating Income (“Cash NOI”)* The Company believes that net income attributable to common stockholders as defined by GAAP is the most appropriate earnings measure. The Company considers Cash NOI an important supplemental measure because it allows investors, analysts and its management to evaluate the operating performance of its investments. The Company defines Cash NOI as total revenues less operating expenses and non-cash revenues. Cash NOI excludes all other financial statement amounts included in net income. Consolidated Debt The principal balances of the Company’s revolving credit facility, term loans, senior unsecured notes, and secured indebtedness as reported in the Company’s condensed consolidated financial statements. Consolidated Debt, Net The carrying amount of the Company’s revolving credit facility, term loans, senior unsecured notes, and secured indebtedness, as reported in the Company’s condensed consolidated financial statements. Consolidated Enterprise Value The Company believes Consolidated Enterprise Value is an important measurement as it is a measure of a company’s value. The Company calculates Consolidated Enterprise Value as market equity capitalization plus Consolidated Debt. Market equity capitalization is calculated as (i) the number of shares of common stock multiplied by the closing price of the Company’s common stock on the last day of the period presented plus (ii) the number of shares of preferred stock multiplied by the closing price of the Company’s preferred stock on the last day of the period presented. Consolidated Enterprise Value includes the Company’s market equity capitalization and Consolidated Debt, less cash and cash equivalents. EBITDAR Earnings before interest, taxes, depreciation, amortization and rent (“EBITDAR”) for a particular facility accruing to the operator/tenant of the property (not the Company) for the period presented. EBITDAR includes an imputed management fee of 5.0% of revenues for Skilled Nursing/Transitional Care facilities and Senior Housing - Leased communities and an imputed management fee of 2.5% of revenues for Specialty Hospitals and Other facilities. The Company uses EBITDAR in determining EBITDAR Coverage. EBITDAR has limitations as an analytical tool. EBITDAR does not reflect historical cash expenditures or future cash requirements for facility capital expenditures or contractual commitments. In addition, EBITDAR does not represent a property's net income or cash flow from operations and should not be considered an alternative to those indicators. The Company utilizes EBITDAR as a supplemental measure of the ability of the Company's operators/tenants and relevant guarantors to generate sufficient liquidity to meet related obligations to the Company. EBITDAR Coverage Represents the ratio of EBITDAR to cash rent for owned facilities (excluding Senior Housing - Managed communities) for the period presented. EBITDAR Coverage is a supplemental measure of a property's ability to generate cash flows for the operator/tenant (not the Company) to meet the operator's/ tenant's related cash rent and other obligations to the Company. However, its usefulness is limited by, among other things, the same factors that limit the usefulness of EBITDAR. EBITDAR Coverage includes only Stabilized Facilities and excludes significant tenants with meaningful credit enhancement through guarantees (which include Genesis, Holiday and two legacy CCP tenants), one Ancillary Supported Tenant and facilities for which data is not available or meaningful. EBITDARM Earnings before interest, taxes, depreciation, amortization, rent and management fees (“EBITDARM”) for a particular facility accruing to the operator/tenant of the property (not the Company), for the period presented. The Company uses EBITDARM in determining EBITDARM Coverage. The usefulness of EBITDARM is limited by the same factors that limit the usefulness of EBITDAR. Together with EBITDAR, the Company utilizes EBITDARM to evaluate the core operations of the properties by eliminating management fees, which may vary by operator/tenant and operating structure. 28 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
APPENDIX Reporting Definitions EBITDARM Coverage Represents the ratio of EBITDARM to cash rent for owned facilities (excluding Senior Housing - Managed communities) for the period presented. EBITDARM coverage is a supplemental measure of a property’s ability to generate cash flows for the operator/tenant (not the Company) to meet the operator’s/tenant’s related cash rent and other obligations to the Company. However, its usefulness is limited by, among other things, the same factors that limit the usefulness of EBITDARM. EBITDARM Coverage includes only Stabilized Facilities and excludes significant tenants with meaningful credit enhancement through guarantees (which include Genesis, Holiday and two legacy CCP tenants), one Ancillary Supported Tenant and facilities for which data is not available or meaningful. Fixed Charge Coverage Ratio EBITDAR (including adjustments for one-time and pro forma items) for the period indicated (one quarter in arrears) for all operations of any entities that guarantee the tenants’ lease obligations to the Company divided by the same period cash rent expense, interest expense and mandatory principal payments for operations of any entity that guarantees the tenants’ lease obligation to the Company. Fixed Charge Coverage is a supplemental measure of a guarantor’s ability to meet the operator’s/tenant’s cash rent and other obligations to the Company should the operator/tenant be unable to do so itself. However, its usefulness is limited by, among other things, the same factors that limit the usefulness of EBITDAR. Fixed Charge Coverage is calculated by the Company as described above based on information provided by guarantors without independent verification by the Company and may differ from similar metrics calculated by the guarantors. Funds From Operations Attributable to Common Stockholders (“FFO”) and Adjusted Funds from Operations Attributable to Common Stockholders (“AFFO”)* The Company believes that net income attributable to common stockholders as defined by GAAP is the most appropriate earnings measure. The Company also believes that funds from operations attributable to common stockholders, or FFO, as defined in accordance with the definition used by the National Association of Real Estate Investment Trusts (“NAREIT”), and adjusted funds from operations attributable to common stockholders, or AFFO (and related per share amounts) are important non-GAAP supplemental measures of the Company’s operating performance. Because the historical cost accounting convention used for real estate assets requires straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. However, since real estate values have historically risen or fallen with market and other conditions, presentations of operating results for a real estate investment trust that uses historical cost accounting for depreciation could be less informative. Thus, NAREIT created FFO as a supplemental measure of operating performance for real estate investment trusts that excludes historical cost depreciation and amortization, among other items, from net income attributable to common stockholders, as defined by GAAP. FFO is defined as net income attributable to common stockholders, computed in accordance with GAAP, excluding gains or losses from real estate dispositions, plus real estate depreciation and amortization, net of amounts related to noncontrolling interests, plus the Company’s share of depreciation and amortization related to our unconsolidated joint venture, and real estate impairment charges. AFFO is defined as FFO excluding merger and acquisition costs, stock-based compensation expense, straight-line rental income adjustments, amortization of above and below market lease intangibles, non-cash interest income adjustments, non-cash interest expense, change in fair value of contingent consideration, non-cash portion of loss on extinguishment of debt, provision for doubtful straight-line rental income, loan losses and other reserves and deferred income taxes, as well as other non-cash revenue and expense items (including ineffectiveness gain/loss on derivative instruments, and non-cash revenue and expense amounts related to noncontrolling interests) and our share of non-cash adjustments related to our unconsolidated joint venture. The Company believes that the use of FFO and AFFO (and the related per share amounts), combined with the required GAAP presentations, improves the understanding of the Company's operating results among investors and makes comparisons of operating results among real estate investment trusts more meaningful. The Company considers FFO and AFFO to be useful measures for reviewing comparative operating and financial performance because, by excluding the applicable items listed above, FFO and AFFO can help investors compare the operating performance of the Company between periods or as compared to other companies. While FFO and AFFO are relevant and widely used measures of operating performance of real estate investment trusts, they do not represent cash flows from operations or net income attributable to common stockholders as defined by GAAP and should not be considered an alternative to those measures in evaluating the Company’s liquidity or operating performance. FFO and AFFO also do not consider the costs associated with capital expenditures related to the Company’s real estate assets nor do they purport to be indicative of cash available to fund the Company’s future cash requirements. Further, the Company’s computation of FFO and AFFO may not be comparable to FFO and AFFO reported by other real estate investment trusts that do not define FFO in accordance with the current NAREIT definition or that interpret the current NAREIT definition or define AFFO differently than the Company does. Investment Represents the carrying amount of real estate assets after adding back accumulated depreciation and amortization and excludes net intangible assets and liabilities. Investment also includes the Company’s pro rata share of the real estate assets held in the Company’s unconsolidated joint venture. Market Capitalization Total common shares of Sabra outstanding multiplied by the closing price per common share as of a given period. Net Operating Income (“NOI”)* The Company believes that net income attributable to common stockholders as defined by GAAP is the most appropriate earnings measure. The Company considers NOI an important supplemental measure because it allows investors, analysts and its management to evaluate the operating performance of its investments. The Company defines NOI as total revenues less operating expenses. NOI excludes all other financial statement amounts included in net income. 29 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018
APPENDIX Reporting Definitions Normalized FFO and Normalized AFFO* Normalized FFO and Normalized AFFO represent FFO and AFFO, respectively, adjusted for certain income and expense items that the Company does not believe are indicative of its ongoing operating results. The Company considers Normalized FFO and Normalized AFFO to be useful measures to evaluate the Company’s operating results excluding these income and expense items to help investors compare the operating performance of the Company between periods or as compared to other companies. Normalized FFO and Normalized AFFO do not represent cash flows from operations or net income as defined by GAAP and should not be considered an alternative to those measures in evaluating the Company’s liquidity or operating performance. Normalized FFO and Normalized AFFO also do not consider the costs associated with capital expenditures related to the Company’s real estate assets nor do they purport to be indicative of cash available to fund the Company’s future cash requirements. Further, the Company’s computation of Normalized FFO and Normalized AFFO may not be comparable to Normalized FFO and Normalized AFFO reported by other real estate investment trusts that do not define FFO in accordance with the current NAREIT definition or that interpret the current NAREIT definition or define FFO and AFFO or Normalized FFO and Normalized AFFO differently than the Company does. Occupancy Percentage Occupancy Percentage represents the facilities’ average operating occupancy for the period indicated. The percentages are calculated by dividing the actual census from the period presented by the available beds/units for the same period. Occupancy includes only Stabilized Facilities and excludes facilities for which data is not available or meaningful. Occupancy Percentage for the Company’s unconsolidated joint venture is weighted to reflect the Company’s pro rata share. REVPOR REVPOR represents the average revenues generated per occupied room per month at Senior Housing - Managed communities for the period indicated. It is calculated as resident fees and services revenues divided by average monthly occupied room days. REVPOR includes only Stabilized Facilities. REVPOR for the Company’s unconsolidated joint venture is weighted to reflect the Company’s pro rata share. Senior Housing Senior Housing communities include independent living, assisted living, continuing care retirement and memory care communities. Skilled Mix Skilled Mix is defined as the total Medicare and non-Medicaid managed care patient revenue at Skilled Nursing/Transitional Care facilities divided by the total revenues at Skilled Nursing/Transitional Care facilities for the period indicated. Skilled Mix includes only Stabilized Facilities and excludes facilities for which data is not available or meaningful. Skilled Nursing/Transitional Care Skilled Nursing/Transitional Care facilities include skilled nursing, transitional care, multi-license designation and mental health facilities. Specialty Hospitals and Other Includes acute care, long-term acute care, rehabilitation and behavioral hospitals, facilities that provide residential services, which may include assistance with activities of daily living, and other facilities not classified as Skilled Nursing/Transitional Care or Senior Housing. Stabilized Facility At the time of acquisition, the Company classifies each facility as either stabilized or pre-stabilized. In addition, the Company may classify a facility as pre- stabilized after acquisition. Circumstances that could result in a facility being classified as pre-stabilized include newly completed developments, facilities undergoing major renovations or additions, facilities being repositioned or transitioned to new operators, and significant transitions within the tenants’ business model. Such facilities will be reclassified to stabilized upon maintaining consistent occupancy (85% for Skilled Nursing/Transitional Care facilities and 90% for Senior Housing communities) but in no event beyond 24 months after the date of classification as pre-stabilized. Stabilized Facilities exclude (i) Senior Housing - Managed communities, (ii) facilities held for sale, (iii) facilities being sold pursuant to the Company’s CCP portfolio repositioning, (iv) facilities being transitioned to a new operator, (v) facilities being transitioned from leased by the Company to being operated by the Company and (vi) facilities acquired during the three months preceding the period presented. Total Debt Consolidated Debt plus the Company’s pro rata share of the principal balances of the debt of the Company’s unconsolidated joint venture. Total Debt, Net Consolidated Debt, Net plus the Company’s pro rata share of the carrying amount of the debt of the Company’s unconsolidated joint venture. Total Enterprise Value Consolidated Enterprise Value plus the Company’s pro rata share of the principal balances of the debt of the Company’s unconsolidated joint venture. *Non-GAAP Financial Measures Reconciliations, definitions and important discussions regarding the usefulness and limitations of the Non-GAAP Financial Measures used in this supplement can be found at http://www.sabrahealth.com/investors/financials/reports-presentations/non-gaap. 30 SABRA 3Q 2018 SUPPLEMENTAL INFORMATION September 30, 2018